The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Pharmora Solutions
Leadership - Pharmora SOlutions
Stock and Other Ownership Interests - Pharmora Solutions
Consulting or Advisory Role - Centus Biotherapeutics
Travel, Accommodations, Expenses - Centus Biotherapeutics
Efficacy and safety of bevacizumab biosimilar FKB238 versus originator bevacizumab: Results from a phase III trial in patients with non-squamous non-small cell lung cancer (NS-NSCLC).
 
Konstantinos N. Syrigos
Honoraria - Bristol-Myers Squibb; MSD; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; MSD Oncology; Roche
 
Dongyue Fu
Employment - AstraZeneca/MedImmune
Stock and Other Ownership Interests - AstraZeneca/MedImmune
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Centus Biotherapeutics
 
Stephanie Jones
No Relationships to Disclose
 
Zahid Bashir
Employment - TranScrip Partners
Leadership - Centus Biotherapeutics; TranScrip Partners
Consulting or Advisory Role - Centus Biotherapeutics; Centus Biotherapeutics (Inst)
Travel, Accommodations, Expenses - Centus Biotherapeutics